Some studies suggest that GLP-1 analogues or DPP-4 inhibitors improve endothelial functioning by promoting activation of eNOS and enhancing NO production to prevent the progression of hypertension [26, 27] or atherosclerosis [28]. This evidence concerns the gene DPP4 and atherosclerosis.